Alliance for Clinical Trials in Africa

Alliance for Clinical Trials in Africa
Name	Alliance for Clinical Trials in Africa
Formation	1997
Headquarters	Johannesburg, South Africa
Type	Non-profit clinical research network
Region served	Sub-Saharan Africa
Leader title	Director

Alliance for Clinical Trials in Africa

The Alliance for Clinical Trials in Africa is a research network supporting clinical trials across Sub-Saharan Africa linked to institutions such as University of the Witwatersrand, University of Nairobi, Makerere University, University of Ibadan, and Kwame Nkrumah University of Science and Technology. The network collaborates with funders and agencies including National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, European Commission, and World Health Organization to advance trials in areas aligned with initiatives like HIV/AIDS pandemic, tuberculosis pandemic, malaria eradication, maternal health, and child health. It operates within regulatory frameworks influenced by bodies such as South African Health Products Regulatory Authority, Nigeria Centre for Disease Control, Kenya Medical Research Institute, Uganda National Council for Science and Technology, and African Union policy instruments.

History and Founding

The Alliance emerged in the late 1990s through collaborations among investigators from University of Cape Town, Harvard University, Johns Hopkins University, Imperial College London, and University of Oxford following dialogues at meetings hosted by African Academy of Sciences and International AIDS Society. Early convenings included participants from Centers for Disease Control and Prevention, Fogarty International Center, European & Developing Countries Clinical Trials Partnership, Médecins Sans Frontières, and Bill & Melinda Gates Foundation which shaped charters and memoranda of understanding. Founding activities were influenced by precedents set by Greenwood Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, and trials coordinated with World Health Organization task forces on antiretroviral therapy and vaccine development.

Organizational Structure and Governance

Governance comprises a board drawn from leaders at University of the Witwatersrand, University of Malawi, University of Ghana, University of Zambia, and Addis Ababa University along with representatives from National Institutes of Health, Wellcome Trust, and European Commission. Operational units include clinical operations, biostatistics, pharmacovigilance, and ethics, staffed by personnel from London School of Hygiene & Tropical Medicine, Karolinska Institutet, McMaster University, Columbia University, and Stellenbosch University. Advisory committees include ethicists from University of Cape Town, regulatory liaisons tied to South African Health Products Regulatory Authority and Kenya Pharmacy and Poisons Board, and data safety monitoring boards with members who have served on panels for US Food and Drug Administration and European Medicines Agency.

Research Programs and Clinical Trials

Programs span interventional trials for HIV/AIDS pandemic including antiretroviral strategy studies coordinated with UNAIDS and vaccine efficacy trials linked to HIV Vaccine Trials Network, as well as malaria eradication drug and vaccine trials aligned with PATH and Malaria Vaccine Initiative. Trials address tuberculosis pandemic diagnostics and therapeutics in collaboration with Stop TB Partnership and The Union (International Union Against Tuberculosis and Lung Disease), and maternal and neonatal interventions evaluated alongside Saving Mothers initiatives and Every Woman Every Child frameworks. Studies have incorporated methodologies from Randomized Controlled Trial designs used in trials connected to Duke University, University of California, San Francisco, and Yale University.

Partnerships and Collaborations

The Alliance maintains formal partnerships with National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, European & Developing Countries Clinical Trials Partnership, World Health Organization, African Academy of Sciences, UNAIDS, Centers for Disease Control and Prevention, PATH, Malaria Vaccine Initiative, HIV Vaccine Trials Network, and academic collaborators including University of Oxford, Harvard University, Johns Hopkins University, Imperial College London, and London School of Hygiene & Tropical Medicine. Collaborative networks extend to regional bodies such as African Union and national agencies like Kenya Medical Research Institute, Nigeria Centre for Disease Control, and Uganda National Council for Science and Technology.

Capacity Building and Training

Capacity building includes investigator training programs conducted with Fogarty International Center, bioethics courses modeled on curricula from University of Cape Town and Makerere University, and laboratory strengthening via partnerships with Africa Centres for Disease Control and Prevention and South African National Bioinformatics Institute. Short courses and fellowships have been co-sponsored by Wellcome Trust, National Institutes of Health, European Commission, and universities including McGill University, Karolinska Institutet, and Monash University to support trial management, biostatistics, and pharmacovigilance.

Funding and Financial Support

Funding sources include grants and contracts from National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, and European Commission programs such as Horizon 2020 and successor mechanisms, alongside support from Centers for Disease Control and Prevention and philanthropic contributions channeled through GAVI, the Vaccine Alliance and Global Fund to Fight AIDS, Tuberculosis and Malaria. Financial oversight follows standards adopted by International Committee of Medical Journal Editors and auditing practices consistent with multinational funders.

Impact and Notable Contributions

Contributions include multicenter trial data informing treatment guidelines adopted by World Health Organization, implementation research that influenced policies at Ministry of Health (South Africa), Ministry of Health (Kenya), and Ministry of Health (Uganda), and capacity gains reflected in publications in journals allied with The Lancet, New England Journal of Medicine, Nature Medicine, PLOS Medicine, and BMJ. Collaborative trials have advanced interventions connected to HIV Vaccine Trials Network outcomes, Malaria Vaccine Initiative vaccine evaluations, and Stop TB Partnership therapeutic regimens, while alumni have taken leadership roles at institutions such as University of Cape Town, Makerere University, University of Nairobi, Johns Hopkins University, and Harvard University.

Category:Medical research organizations